1. Home
  2. INDB vs EWTX Comparison

INDB vs EWTX Comparison

Compare INDB & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Independent Bank Corp.

INDB

Independent Bank Corp.

HOLD

Current Price

$78.69

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$33.46

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDB
EWTX
Founded
1907
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.5B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
INDB
EWTX
Price
$78.69
$33.46
Analyst Decision
Hold
Buy
Analyst Count
4
6
Target Price
$87.00
$39.00
AVG Volume (30 Days)
271.2K
1.3M
Earning Date
04-16-2026
05-07-2026
Dividend Yield
3.32%
N/A
EPS Growth
N/A
N/A
EPS
1.63
N/A
Revenue
N/A
N/A
Revenue This Year
$33.83
N/A
Revenue Next Year
$5.85
N/A
P/E Ratio
$48.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.78
$12.31
52 Week High
$87.00
$39.96

Technical Indicators

Market Signals
Indicator
INDB
EWTX
Relative Strength Index (RSI) 53.42 52.36
Support Level $78.54 $29.18
Resistance Level $79.46 $35.00
Average True Range (ATR) 1.45 1.57
MACD 0.22 -0.12
Stochastic Oscillator 68.32 33.87

Price Performance

Historical Comparison
INDB
EWTX

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: